Reuters: Regulatory News: UPDATE 1-US House panel seeks FDA documents on meningitis-linked firm

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-US House panel seeks FDA documents on meningitis-linked firm Oct 17th 2012, 20:28 Wed Oct 17, 2012 4:28pm EDT WASHINGTON Oct 17 (Reuters) - A U.S. congressional committee that oversees drug safety issues asked the Food and Drug Administration on Wednesday to provide documents on federal and state inspections of a Massachusetts pharmacy linked to a deadly meningitis outbreak that has killed 19 people. In a letter to FDA Commissioner Margaret Hamburg, the House of Representatives Energy and Commerce Committee said it was requesting documents dating back to 2004 as part of a probe to determine what actions regulators took after they concluded that the pharmacy's facilities posed potential risks to public health. "Given the risk to public health posed by this outbreak, the committee expects the FDA to comply with this request promptly," said the letter signed by Republican panel chairman Fred Upton, top Democrat Henry Waxman and six other committee members. The panel requested FDA documents pertaining to the New England Compounding Center, which is at the heart of a meningitis outbreak linked to tainted steroid treatments and other products. Lawmakers also sought documents involving Ameridose LLC, a second pharmacy that shares ownership with NECC, as well as communications with state regulators and Hamburg's office. Both NECC and Ameridose have suspended operations.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions